Center for Infectious Diseases, The University of Texas School of Public Health at Houston.
J Infect Dis. 2014 Apr 1;209(7):1007-15. doi: 10.1093/infdis/jit615. Epub 2013 Nov 18.
Published data are equivocal about the relative rates of male-to-female and female-to-male human papillomavirus (HPV) transmission. Our objective was to estimate genital HPV incidence among heterosexual partners from a broad age range and to investigate the effects of monogamy and relationship duration on incidence.
HPV genotyping was conducted for heterosexual partners, aged 18-70 years, from Tampa, Florida, who provided genital exfoliated cell specimens at semiannual visits during a 2-year study. The rate of incident HPV detection was assessed for 99 couples, and transmission incidence was estimated among a subset of 65 discordant couples. We also evaluated the effect of monogamy and relationship duration on transmission incidence.
Couples were followed up for a median of 25 months and had a mean age of 33 years for both sexes. The HPV type-specific transmission incidence rate was 12.3 (95% confidence interval, 7.1-19.6) per 1000 person-months for female-to-male transmission and 7.3 (95% confidence interval, 3.5-13.5) per 1000 person-months for male-to-female transmission. Regardless of monogamy status or relationship duration, there was a similar pattern of increased incident HPV detection among men compared with women.
HPV may be transmitted more often from women to men than from men to women, suggesting a need for prevention interventions, such as vaccination, for men.
已发表的数据对于男性向女性和女性向男性的人乳头瘤病毒(HPV)传播的相对速率存在争议。我们的目的是估计来自广泛年龄范围的异性伴侣的生殖器 HPV 发病率,并研究一夫一妻制和关系持续时间对发病率的影响。
对年龄在 18-70 岁的佛罗里达州坦帕市的异性伴侣进行 HPV 基因分型,这些伴侣在为期 2 年的研究中每半年进行一次生殖器脱落细胞标本检查。对 99 对夫妇评估了 99 对夫妇的 HPV 检出率,对 65 对 HPV 不匹配的夫妇评估了 HPV 传播率。我们还评估了一夫一妻制和关系持续时间对传播率的影响。
夫妻随访中位数为 25 个月,两性的平均年龄均为 33 岁。女性向男性传播的 HPV 型别特异性传播发病率为 12.3(95%置信区间,7.1-19.6)/1000 人月,男性向女性传播的 HPV 型别特异性传播发病率为 7.3(95%置信区间,3.5-13.5)/1000 人月。无论一夫一妻制状态或关系持续时间如何,男性的 HPV 检出率都高于女性。
HPV 可能更常从女性传播给男性,而不是从男性传播给女性,这表明需要针对男性开展预防干预措施,如疫苗接种。